These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25792473)

  • 1. Clinical significance of the VEGF level in urinary bladder carcinoma.
    Sankhwar M; Sankhwar SN; Abhishek A; Rajender S
    Cancer Biomark; 2015; 15(4):349-55. PubMed ID: 25792473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation and Significance of Urinary Soluble Fas and Vascular Endothelial Growth Factor in Bladder Urothelial Cancer.
    Yang H; Wang Z; Guo Y; Wang Z
    Dis Markers; 2015; 2015():383509. PubMed ID: 26798188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of vascular endothelial growth factor and endostatin in urine for diagnosis of bladder cancer.
    Cheng D; Liang B; Li Y
    Tumori; 2012 Nov; 98(6):762-7. PubMed ID: 23389364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates.
    Crew JP; O'Brien T; Bicknell R; Fuggle S; Cranston D; Harris AL
    J Urol; 1999 Mar; 161(3):799-804. PubMed ID: 10022687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
    Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective pilot evaluation of urinary and immunohistochemical markers as predictors of clinical stage of urothelial carcinoma of the bladder.
    Krupski T; Moskaluk C; Boyd JC; Theodorescu D
    BJU Int; 2000 Jun; 85(9):1027-32. PubMed ID: 10848689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic efficacy of urinary TGF-beta1 and VEGF in bladder cancer: comparison with voided urine cytology.
    Eissa S; Salem AM; Zohny SF; Hegazy MG
    Cancer Biomark; 2007; 3(6):275-85. PubMed ID: 18048965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder transitional cell carcinoma: correlation of contrast enhancement on computed tomography with histological grade and tumour angiogenesis.
    Xie Q; Zhang J; Wu PH; Jiang XQ; Chen SL; Wang QL; Xu J; Chen GD; Deng JH
    Clin Radiol; 2005 Feb; 60(2):215-23. PubMed ID: 15664576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of urinary vascular endothelial growth factor in patients with superficial bladder tumors.
    Jeon SH; Lee SJ; Chang SG
    Oncol Rep; 2001; 8(6):1265-7. PubMed ID: 11605046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of VEGF and tumor angiogenesis in bladder cancer].
    Wang S; Xia T; Zhang Z; Kong X; Zeng L; Mi P; Xue Z
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):34-6. PubMed ID: 11831983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
    Bian W; Xu Z
    Int J Urol; 2007 Feb; 14(2):108-11. PubMed ID: 17302565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.
    Urquidi V; Goodison S; Kim J; Chang M; Dai Y; Rosser CJ
    Urology; 2012 May; 79(5):1185.e1-6. PubMed ID: 22386755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma.
    Sun YW; Xuan Q; Shu QA; Wu SS; Chen H; Xiao J; Xiang P; Zhu YP; Wang FL; Zhao ST
    Genet Mol Res; 2013 Apr; 12(2):1045-53. PubMed ID: 23613251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of vascular endothelial growth factors A, C and D as indicators of lymphangiogenesis and angiogenesis in invasive and non-invasive urothelial carcinoma bladder.
    Khadim MT; Ahmed SA; Khan FA; Ikram A; Shaikh SY
    J Pak Med Assoc; 2015 Aug; 65(8):851-6. PubMed ID: 26228330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between Her2 oncoprotein, VEGF expression, MVD and clinicopathological parameters in gastric cancer.
    Bădescu A; Georgescu CV; Vere CC; Crăiţoiu S; Grigore D
    Rom J Morphol Embryol; 2012; 53(4):997-1005. PubMed ID: 23303024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between early enhanced helical CT and tumor angiogenesis in bladder cancer].
    Xie Q; Zhang J; Jiang XQ; Chen SL; Wang QL; Xu J; Gu JH; Zheng YJ
    Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):569-72. PubMed ID: 14690564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BLCA-4 expression is related to MMP-9, VEGF, IL-1α and IL-8 in bladder cancer but not to PEDF, TNF-α or angiogenesis.
    Feng C; Wu Z; Guo T; Jiang H; Guan M; Zhang Y; Wen H; Ding Q
    Pathol Biol (Paris); 2012 Jun; 60(3):e36-40. PubMed ID: 22197408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer.
    Wang YH; Yeh SD; Wu MM; Liu CT; Shen CH; Shen KH; Pu YS; Hsu LI; Chiou HY; Chen CJ
    J Hazard Mater; 2013 Nov; 262():1139-46. PubMed ID: 23009795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
    Suzuki K; Morita T; Tokue A
    Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.